Skip to main content

Biogen ownership: holders and insider trading

  • BIIB · Nasdaq
  • Biotechnology
  • S&P 500
$253.40+1.17%Close 13 Nov 2026 · Market value $37.59B

As filed, its directors and officers own 0.2% of the shares (proxy statement, 21 Apr 2026); 1,036 institutional managers reported holding 96.2% at 30 Jun 2026. Over the last twelve months, insiders bought $585 and sold $905.4K of shares on the open market, $905.4K of it under 10b5-1 plans set in advance.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
FMR LLCHolder18.3M12.4%Schedule 13G30 Jun 2026
Fidelity (FMR)Institution18.2M12.32%*Form 13F30 Jun 2026
VanguardInstitution17.8M12.05%*Form 13F30 Jun 2026
BlackRock, Inc.Holder16.0M10.81%*Form 13F30 Jun 2026
PRIMECAP Management CompanyHolder15.2M10.25%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder11.0M7.48%Schedule 13G31 Mar 2026
State Street CorporationHolder7.3M4.97%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution4.4M3.01%*Form 13F30 Jun 2026
Wellington ManagementInstitution3.1M2.11%*Form 13F30 Jun 2026
Norges BankInstitution2.6M1.75%*Form 13F30 Jun 2026
Morgan StanleyInstitution2.4M1.63%*Form 13F30 Jun 2026
UBSInstitution2.3M1.55%*Form 13F30 Jun 2026
Aqr Capital Management LLCInstitution1.9M1.31%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution1.8M1.23%*Form 13F30 Jun 2026
InvescoInstitution1.8M1.22%*Form 13F30 Jun 2026
AmundiInstitution1.5M1.03%*Form 13F30 Jun 2026
Legal & GeneralInstitution1.5M1.01%*Form 13F30 Jun 2026
Northern TrustInstitution1.4M0.97%*Form 13F30 Jun 2026
Boston PartnersInstitution1.3M0.85%*Form 13F30 Jun 2026
Goldman SachsInstitution1.2M0.83%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Minor Lloyd · Director4 Aug 2026Open-market sale (10b5-1 plan)−593$200.96$119.2K
Minor Lloyd · Director3 Aug 2026Open-market sale (10b5-1 plan)−593$203.34$120.6K
HAWKINS WILLIAM A · Director9 Jun 2026Grant or award+1.5K——
SHERWIN STEPHEN A · Director9 Jun 2026Grant or award+1.5K——
Rowinsky Eric K · Director9 Jun 2026Grant or award+1.5K——
Mantas Jesus B · Director9 Jun 2026Grant or award+1.5K——
LANGER SUSAN · Director9 Jun 2026Grant or award+1.5K——
Patolawala Monish D · Director9 Jun 2026Grant or award+1.5K——
Pangalos Menelas N · Director9 Jun 2026Option exercise+2.4K——
Pangalos Menelas N · Director9 Jun 2026Grant or award+1.5K——
Minor Lloyd · Director9 Jun 2026Grant or award+1.5K——
Freire Maria C · Director9 Jun 2026Grant or award+2.0K——
Keeney Adam · Head of Corporate Development1 May 2026Option exercise+939——
Keeney Adam · Head of Corporate Development1 May 2026Shares withheld for tax−455$187.06$85.11K
Godbout Sean · Chief Accounting Officer1 Apr 2026Shares withheld for tax−54$183.78$9.92K
Godbout Sean · Chief Accounting Officer1 Apr 2026Option exercise+181——
Murphy Nicole · Head of Pharm Ops and Tech12 Feb 2026Open-market purchase+3$195.04$585
Singhal Priya · Head of Development9 Feb 2026Open-market sale (10b5-1 plan)−2.7K$199.83$531.5K
Viehbacher Christopher · President and CEO · Director6 Feb 2026Option exercise+9.0K——
Viehbacher Christopher · President and CEO · Director6 Feb 2026Shares withheld for tax−6.6K$201.18$1.33M
Viehbacher Christopher · President and CEO · Director6 Feb 2026Option exercise+15.5K——
Viehbacher Christopher · President and CEO · Director6 Feb 2026Shares withheld for tax−4.4K$201.18$876.3K
Singhal Priya · Head of Development6 Feb 2026Option exercise+2.2K——
Singhal Priya · Head of Development6 Feb 2026Shares withheld for tax−1.4K$201.18$284.1K
Singhal Priya · Head of Development6 Feb 2026Option exercise+4.7K——

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

BIIB in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.